Esperion: Funding, Investors & Team (Oct 2026)
Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.
Esperion has raised $225M across 2 funding rounds on record, the most recent an undisclosed round announced in May 2026.
Esperion Company Profile and Key Stats
Latest funding round on record: May 2026.
Esperion Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Esperion raised $225M in a Post-IPO Equity announced in Dec 2021.
4.4 years later, an undisclosed round was announced in May 2026 with no disclosed amount.
Esperion Founders and Leadership Team
Contact details for the Esperion team: 1 has a LinkedIn profile.
Start 14-day free trial →Esperion Funding Compared to Other Biotechnology Startups
Funded Startups Like Esperion in Biotechnology and Ann Arbor
Companies Similar to Esperion
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Esperion Funding FAQs
What does Esperion do?
Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.
How much funding has Esperion raised?
Esperion has raised $225M across 2 rounds on record.
When did Esperion last raise funding?
Esperion's most recent funding round on record was announced in May 2026. The amount was not disclosed.
Who founded Esperion?
FundedIQ lists Sheldon Koenig (Founder) at Esperion.
Who is the CEO of Esperion?
Tim Mayleben is listed as CEO at Esperion.
Where is Esperion headquartered?
Esperion is based in Ann Arbor, Michigan, United States.
How many employees does Esperion have?
Esperion is in the 251-500 employee band.
About FundedIQ's Esperion Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Esperion is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.